Synovial sarcoma of the buttocks presenting with a non-healing wound and rapid progression after local resection: a case report
© Zhang et al.; licensee BioMed Central Ltd. 2012
Received: 4 February 2012
Accepted: 28 June 2012
Published: 28 June 2012
Synovial sarcoma is a malignant mesenchymal neoplasm that is frequently misdiagnosed as a benign condition because of its small size, slow growth, and well-delineated appearance. Rapid spread and early death occur rarely. Here we report a case of synovial sarcoma of the buttocks presenting with a non-healing wound and rapid progression after local resection in a 23-year-old woman. She initially found a slightly painful subcutaneous mass in the left buttock and underwent local excision. Postoperatively, she developed a non-healing wound that did not respond to conventional antibiotic therapy and local wound care, and pitting edema of the lower extremities. A magnetic resonance imaging scan revealed a large heterogeneous, irregular mass in the buttocks with regional lymph node involvement. Histological and immunohistochemical analyses suggested the diagnosis of a poorly differentiated synovial sarcoma. Her condition deteriorated dramatically shortly thereafter; she developed systemic edema and died of respiratory failure. This case suggests that synovial sarcoma may be fatal within months of recognition if improperly managed and stresses the importance of adequate pre-surgical evaluation and postoperative pathological analysis in the management of a subcutaneous mass.
KeywordsNon-healing wound rapid progression synovial sarcoma
Synovial sarcoma is a malignant mesenchymal neoplasm that constitutes 8 to 10% of all sarcomas and has an annual incidence of 2.5 per 100,000. It mainly affects adults in the third to fifth decades of life  and usually arises in the extremities, especially the lower extremities around the knees . This malignancy has a highly variable course. It is frequently misdiagnosed as a benign condition as a consequence of its small size, slow growth and well-delineated appearance. Overall, survival rates are 23.5 to 64% at 5 years and 11.2 to 34% at 10 years . Rapid spread and early death occur infrequently. In addition, the development of non-healing wounds following local resection is rarely seen in patients with a synovial sarcoma. Here, we report a case of synovial sarcoma of the buttock that presented with a non-healing wound and rapid progression after local resection.
A 23-year-old woman was admitted to our hospital due to the development of a non-healing postoperative wound for approximately 4 months. In January 2011, she found a slightly painful subcutaneous mass that measured 1 × 1.5 cm in the left buttock and underwent local excision at a local hospital. On postoperative day 2, she developed bleeding from the wound and received hemostatic interventions. However, the wound remained unhealed and continued to produce purulent exudates, with no obvious improvement after repeated dressing changes. On March 26th, 2011, the patient was referred to another hospital, where she underwent surgical debridement. Postoperatively, the wound deteriorated rapidly and developed a cauliflower-like growth. Meanwhile, she developed pitting edema of the lower extremities. Her general condition worsened.
As the patient developed severe anemia, hypoproteinemia and severe edema, she was treated with a blood transfusion, fluid infusion, supplementation with albumin and plasma, and regular dressing changes to maintain stable vital signs. However, her condition deteriorated dramatically and she rapidly developed systemic edema. As a result, she developed dyspnea, anorexia and anuria (<100 mL/d). The patient died of respiratory failure within a week after admission.
Synovial sarcoma is the third most common histological type of soft tissue sarcoma of the extremities, which mainly affects adolescents and young adults . It is slightly more common in men than in women, with a male-to-female ratio of 3:2 . Despite its name, synovial sarcoma does not originate from synovial tissue, but from multipotent stem cells that differentiate into mesenchymal and/or epithelial structures . It is characterized by a unique t(X;18)(p11;q11) chromosomal translocation, which leads to the formation of the SS18-SSX fusion gene . Currently, the best treatment for synovial sarcoma remains undefined, and complete surgical excision of the tumor mass followed by adjuvant radiotherapy and/or chemotherapy is the preferred current choice .
Synovial sarcoma often has no specific clinical presentations that distinguish it from other sarcomas. Typically, it presents as a slowly enlarging, deep-seated mass, which is sometimes slightly painful. It is often misdiagnosed as a benign lesion, and simple excision is performed without adequate pre-surgical evaluation. In particular, as the majority of subcutaneous soft-tissue lesions are benign or inflammatory, simple excision is often performed without a biopsy by physicians and surgeons who do not have specific training in oncology . As a result, some aggressive tumors, including synovial sarcoma, can recur within years. Therefore, an early diagnosis is extremely important for the successful treatment of soft tissue synovial sarcoma. Subcutaneous sarcomas have been reported to account for approximately 30 % of all soft tissue sarcomas . In our case, the first clinical sign of synovial sarcoma was a slightly painful subcutaneous mass, and the mass was excised simply. The poor outcome of our patient further stresses the importance of adequate pre-surgical evaluation and post-surgical pathological analysis in the management of a subcutaneous mass.
Although synovial sarcomas are a high-grade soft tissue malignancy, most are characterized by slow growth. The mass may be present for an extended period before presentation and rapid spread and early deaths are seen only occasionally. In the present case, the disease progressed rapidly and the patient died within 4 months of symptom recognition. Given the small tumor size at presentation and the subsequent rapid disease progression, we surmise that local invasion and lymph node metastasis was likely to have occurred before the initial local excision of the mass. Therefore, a wide excision plus adjuvant radiotherapy and/or chemotherapy could have been performed. In addition, for the local excision of a subcutaneous tumor, violation of the underlying fascia may facilitate tumor local invasion, as the fascia provides an excellent deep barrier to tumor spread . Overall, benign tumors should be treated with a marginal excision, whereas malignant tumors should be widely excised. It is important to obtain adequate ablative margins and prevent local recurrence in patients with synovial sarcoma .
The development of a non-healing wound that does not respond to conventional antibiotic therapy and local wound care is another interesting point of our case. Although cancer has been identified to be a common cause of non-healing wounds , there have been very few reports of patients with synovial sarcoma who developed a non-healing wound. Several reasons may explain the development of a non-healing wound in our patient. Firstly, the sarcoma itself can give rise to wounds. Secondly, severe edema can slow the rate of healing, as dehydration adversely affects optimum wound healing by disturbing cellular metabolism and reducing circulatory blood volume [11, 12]. Finally, malnutrition may delay wound healing, as adequate nutrition is essential for effective wound healing . Interestingly, a recent report demonstrated that a postoperative non-healing wound that did not respond to conventional therapy was treated successfully with the local application of 3% citric acid ointment for 25 days in a patient with synovial sarcoma of the knee .
MRI is the preferred imaging modality for the evaluation of soft tissue sarcomas because of its excellent tissue contrast and ability to depict the lesion in multiple planes. It is not only useful for evaluating the extent of the tumor and its involvement of adjacent soft-tissue structures, but also for differentiating tumor from muscle tissue and depicting the involvement of neurovascular structures, tendons, fascial/fat planes and bone marrow. On MR images, lesion margins of synovial sarcomas are well defined in 53 to 91% of cases and poorly defined in 9 to 47% . In our case, the lesion was irregular and poorly confined, which was perhaps due to the fact that MRI was performed after local excision and local invasion had occurred. Therefore, preoperative MRI investigations might be more useful for making an early diagnosis of synovial sarcoma. If the findings on preoperative MRI are doubtful, an open or needle biopsy should be performed.
Synovial sarcoma has three major histological subtypes: the biphasic, monophasic and poorly differentiated types . The co-existence of epithelioid cells and spindle cells is a hallmark of the biphasic subtype, while the monophasic subtype is entirely composed of spindle cells . The poorly differentiated subtype is a variant that lacks spindle cells and comprises primitive small round cells. Although there is a strong association between the poorly differentiated subtype and a poor prognosis, this variant of synovial sarcoma shares immunological, ultrastructural and molecular characteristics with the usual form of synovial sarcoma and is often diagnostically challenging [15, 16]. Poorly differentiated synovial sarcoma can be further divided into three types: a large cell epithelioid variant, a small cell variant and a high-grade spindle cell variant . In the present case, the presence of numerous small round cells with a high nucleocytoplasmic ratio was seen. This led to the initial diagnosis of a poorly differentiated synovial sarcoma, which was perhaps a small cell variant.
Immunohistochemically, most synovial sarcomas are positive for vimentin, cytokeratin and EMA, but have a lower immunoreactivity for S-100 and CD34 . Although they often co-express both cytokeratin and EMA, only one of them was positive in some cases . Positive staining for CD99 and bcl-2 is also present in many cases of synovial sarcoma . In addition, expression of calretinin, varying from focal to diffuse, is commonly seen in synovial sarcomas . Our case was strongly positive for vimentin and calretinin, moderately positive for CD99 and EMA, and only partially positive for cytokeratin. In addition, cytogenetics also plays an important role in the diagnosis of synovial sarcoma, especially the poorly differentiated subtype, since the reciprocal chromosomal translocation t(X;18) is highly specific for synovial sarcoma; however, this was not performed in our case.
Although curative resection and adjuvant irradiation can improve the local control of synovial sarcoma, metastases eventually develop in most patients. The lung and skeleton are the most commonly affected sites. Regional lymph nodes are involved in 10 to 23% of patients. In our case, although lung metastasis was not detected, pelvic and inguinal lymph node involvement was observed. The pitting edema could be caused by lymphedema due to the presence of lymph node metastases . Patients who develop metastatic soft tissue sarcoma are incurable in most cases, and judicious use of systemic treatment may provide symptom palliation, prevent rapid disease progression and prolong survival. Unfortunately, our patient deteriorated rapidly and died despite systemic therapy.
In conclusion, we report a case of synovial sarcoma of the buttocks that presented with a non-healing wound and rapid progression after local resection. Despite slow growth in most cases, synovial sarcoma can be fatal within months of recognition if improperly managed. Our case stresses the importance of adequate preoperative evaluation and postoperative pathological analysis in the management of a subcutaneous mass.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Epithelial membrane antigen
Magnetic resonance imaging.
- Weiss SJG: Malignant soft tissue tumors of uncertain type. 2001Google Scholar
- Nishiguchi T, Mochizuki K, Nakayama T, Inoue Y, Ohata K, Wakasa K: A case of synovial sarcoma in the perivertebral space of the neck: clinical presentation, radiological findings and histopathological description. Br J Radiol. 2008, 81: e72-e74. 10.1259/bjr/86130609.View ArticlePubMedGoogle Scholar
- Moatasim A, Haque AU: Monophasic synovial sarcoma diagnosed on FNAC. International Journal of Pathology. 2004, 2: 108-110.Google Scholar
- Zamarron C, Abdulkader I, Alvarez UC, Baron FJ, Prim JM, Ledo RL, Forteza J: Primary synovial sarcoma of the lung. Intern Med. 2006, 45: 679-683. 10.2169/internalmedicine.45.1508.View ArticlePubMedGoogle Scholar
- Haight J, Caprioli R, Esposito M, Macias A, Lucchese M, Davis E: Synovial sarcoma involving the calcaneus and plantar compartment of the foot: a case report. J Foot Ankle Surg. 2010, 49 (398): e391-394.Google Scholar
- de Bruijn DR, Nap JP, van Kessel AG: The (epi)genetics of human synovial sarcoma. Genes Chromosomes Cancer. 2007, 46: 107-117. 10.1002/gcc.20399.View ArticlePubMedGoogle Scholar
- Naka N, Takenaka S, Araki N, Miwa T, Hashimoto N, Yoshioka K, Joyama S, Hamada K, Tsukamoto Y, Tomita Y, Ueda T, Yoshikawa H, Itoh K: Synovial sarcoma is a stem cell malignancy. Stem Cells. 2010, 28: 1119-1131.PubMedGoogle Scholar
- Nakano J, Yokomise H, Huang CL, Misaki N, Chang SS, Okuda M, Kushida Y, Haba R: Progressive growth of primary synovial sarcoma of the lung. Ann Thorac Cardiovasc Surg. 2010, 16: 194-197.PubMedGoogle Scholar
- Gibbs CP, Peabody TD, Mundt AJ, Montag AG, Simon MA: Oncological outcomes of operative treatment of subcutaneous soft-tissue sarcomas of the extremities. J Bone Joint Surg Am. 1997, 79: 888-897.PubMedGoogle Scholar
- Steinstraesser L, Agarwal R, Stricker I, Steinau HU, Al-Benna S: Biphasic synovial sarcoma of the extremity: quadruple approach of isolated limb perfusion, surgical ablation, adipofascial perforator flap and radiation to avoid amputation. Case Rep Oncol. 2011, 4: 222-228. 10.1159/000327845.PubMed CentralView ArticlePubMedGoogle Scholar
- Regan PO: The impact of cancer and its treatment on wound healing. Wounds UK. 2007, 3: 87-Google Scholar
- Naylor W, Laverty D, Mallett J: The Royal Marsden Hospital handbook of wound management in cancer care. 2001, Wiley-Blackwell, OxfordView ArticleGoogle Scholar
- Nagoba BS, Punpale AS, Ayachit R, Gandhi RC, Wadher BJ: Citric acid treatment of postoperative wound in an operated case of synovial sarcoma of the knee. Int Wound J. 2011, 8: 425-427. 10.1111/j.1742-481X.2011.00802.x.View ArticlePubMedGoogle Scholar
- Murphey MD, Gibson MS, Jennings BT, Crespo-Rodriguez AM, Fanburg-Smith J, Gajewski DA: From the archives of the AFIP: imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics. 2006, 26: 1543-1565. 10.1148/rg.265065084.View ArticlePubMedGoogle Scholar
- van de Rijn M, Barr FG, Xiong QB, Hedges M, Shipley J, Fisher C: Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol. 1999, 23: 106-112. 10.1097/00000478-199901000-00012.View ArticlePubMedGoogle Scholar
- Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, Gusterson BA, Cooper CS: Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994, 7: 502-508. 10.1038/ng0894-502.View ArticlePubMedGoogle Scholar
- Wang J-G: Re: primary cardiac synovial sarcoma. Interact Cardiovasc Thorac Surg. 2010, 11: 492-10.1510/icvts.2010.240200A.View ArticlePubMedGoogle Scholar
- Miettinen M, Limon J, Niezabitowski A, Lasota J: Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol. 2001, 25: 610-617. 10.1097/00000478-200105000-00007.View ArticlePubMedGoogle Scholar
- Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB: A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol. 2009, 16: 979-988. 10.1245/s10434-009-0347-2.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.